PubMed HealthSearch

Biomedical subjects

R R Runnells

Publications and source records attributed to R R Runnells.

At least 19 recordsLinked to original sources

Managing infection control, hazards communication, and infectious waste disposal.

Dentistry entered a new era in the 1980s when the development of the AIDS crisis targeted dental facilities as one source of potential cross-infection with pathogenic microorganisms. As governmental agencies "discovered" dentistry, regulations forced practitioners to assume duties not previously required. Also, substantial costs of compliance became a significant consideration to employers. Managing the compliance and cost considerations of governmental regulation requires dedicating personnel, preferably one person, to the management of infection control, hazards communication, and infectious waste disposal tasks. predictably, this person--the safety supervisor--will develop into the new auxiliary specialist of the 1990s.

Communicable Disease Control

Role of disinfectants in infection control.

The ADA Council on Dental Therapeutics recognizes many commercial products as effective for use in dentistry as disinfectants or sterilants. Some of the products act only as disinfectants and do not sterilize; some have an odor that is unpleasant; others stain or bleach surfaces; and some of the formulations are corrosive to metallic surfaces. Therefore, it is essential that, before purchasing a chemical sterilant/disinfectant or a surface disinfectant for routine use, the practitioner, dental hygienist, and assistant obtain as much detailed information as possible. With sufficient information, subsequent decisions may be used on appropriate efficacy criteria, and the potential for product misuse may be reduced.

Communicable Disease Control

Infection control and hazards management. Economics of regulatory compliance.

Dentistry has become subject to rapid change in office safety, including infection control and hazards management. This change includes increasingly diverse governmental regulations and compliance with such regulations, influencing the very basics of dental practice. As all practitioners are moving toward compliance, costs are increasing substantially. Various sources estimate such increases at between 12.5% and 19%, and it is doubtful whether third-party reimbursement will offset these additional costs. As practitioners plan methods for offsetting the costs of office safety, consideration should be given to providing patients oral and printed information to preclude misinterpretation of the reasons for fee escalation caused by implementation of chemical hazards communication, infection control, and waste disposal programs mandated by OSHA, EPA, and state or other regulatory authorities. The decade of the 1990s may well become the period of meeting the formidable microbiological and regulatory challenges of the 1980s.

Communicable Disease Control

An overview of infection control in dental practice.

Although it is not possible to cover all of the ramifications of infection control in prosthodontics, currently available information may be summarized as follows: 1. All dental disciplines must be concerned with the dangers involved in the spread of certain infectious diseases. 2. Prosthodontists and their ancillary personnel may be exposed to certain diseases predominantly found in adult patients, such as hepatitis B and tuberculosis. 3. Dentists must ensure that at least six basic infection control procedures are observed when treating patients. 4. Additional control procedures should be observed in the fabrication and handling of impressions and dental prosthesis. 5. Dental offices and commercial laboratories should work closely together to coordinate control of potential cross-infection between the two disciplines. The control of infectious diseases in prosthodontics is not difficult. It requires the expenditure of a little time, a little money, and most important, a great deal of discipline. The rewards are well worth the additional effort and could even be lifesaving.

Acquired Immunodeficiency Syndrome